Therapieoptionen bei adenoidzystischem Tränendrüsenkarzinom – Fallserie und aktueller Literaturüberblick

Zusammenfassung

Das adenoidzystische Karzinom der Tränendrüse (ACC) stellt einen seltenen malignen orbitalen Tumor mit insgesamt schlechter Prognose dar. Derzeitige Therapieansätze mit radikaler und lokaler Chirurgie, adjuvanter Bestrahlung und neoadjuvanter intraarterieller Chemotherapie werden kontrovers diskutiert. Wir präsentieren 3 Fälle von Patienten mit ACC mit unterschiedlichen Therapiekonzepten und diskutieren diese mit aktuellen Empfehlungen aus der Literatur.

Abstract

Adenoid cystic carcinoma of the lacrimal gland (ACC) is a rare malignant orbital tumour with a poor overall prognosis. Current therapeutic approaches like radical and local surgery, adjuvant radiation and neoadjuvant intra-arterial chemotherapy are controversial. We present three cases of patients with ACC with different therapy concepts and discuss these with current recommendations from the literature.

Schlüsselwörter

adenoidzystisches Karzinom - Orbita - Tränendrüsentumor

Key words

adenoid cystic carcinoma - lacrimal gland tumour - orbit

• Literatur

• 1 Dillon PM, Chakraborty S, Moskaluk CA. et al. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials. Head Neck 2016; 38: 620-627
• 2 Von Holstein SL. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics. Acta Ophthalmol 2013; 91 (Thesis 6): 1-28
• 3 Woo KI, Kim YD, Sa HS. et al. Current treatment of lacrimal gland carcinoma. Curr Opin Ophthalmol 2016; 27: 449-456
• 4 Rose GE, Gore SK, Plowman NP. Cranio-orbital Resection Does Not Appear to Improve Survival of Patients With Lacrimal Gland Carcinoma. Ophthalmic Plast Reconstr Surg 2018;
• 5 Wolkow N, Jakobiec FA, Lee H. et al. Long-term Outcomes of Globe-Preserving Surgery with Proton Beam Radiation for Adenoid Cystic Carcinoma of the Lacrimal Gland. Am J Ophthalmol 2018;
• 6 Sanders JC, Mendenhall WM, Werning JW. et al. Adenoid cystic carcinoma of the lacrimal gland. Am J Otolaryngol 2016; 37: 144-147 doi:10.1016/j.amjoto.2015.09.015
• 7 Esmaeli B, Ahmadi MA, Youssef A. et al. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg 2004; 20: 22-26
• 8 Mallen-St Clair J, Arshi A, Tajudeen B. et al. Epidemiology and treatment of lacrimal gland tumors: a population-based cohort analysis. JAMA Otolaryngol Head Neck Surg 2014; 140: 1110-1116
• 9 Wright JE, Rose GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol 1992; 76: 401-407
• 10 Han J, Kim YD, Woo KI. et al. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland. Ophthalmic Plast Reconstr Surg 2018; 34: 74-78
• 11 Noh JM, Lee E, Ahn YC. Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma. Oncotarget 2016; 7: 60639-60646
• 12 Tse DT, Kossler AL, Feuer WJ. et al. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma. Ophthalmology 2013; 120: 1313-1323 doi:10.1016/j.ophtha.2013.01.027
• 13 Chen TY, Keeney MG, Chintakuntlawar AV. et al. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement. Eye (Lond) 2017; 31: 720-725 doi:10.1038/eye.2016.307